Nucleus Software Exports Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- April 27, 2026
- Posted by: Kashish Aggarwal
- Category: News
Nucleus Software Exports (NUCLEUS) Q4 results for FY26 are expected in May 2026. With Q3 FY26 revenue of Rs 168 Cr and PAT of Rs 52 Cr as the base, the street is watching closely for margin trajectory and management guidance on FY27 demand.
Get Free SEBI-Registered Research on Nucleus Software Exports — Click Here
Nucleus Software Exports Q4 FY26 Earnings Preview — What to Expect
Indian IT companies navigate a cautious macro environment in Q4 FY26, with large deal wins providing revenue visibility, AI-led services gaining commercial traction and margin improvement from operational efficiency partially offsetting slow discretionary spending recovery.
Nucleus Software Exports Q4 Results 2026 — Date and Key Estimates
| Parameter | Q3 FY26 Actual | Q4 FY26 Estimate | YoY Growth |
|---|---|---|---|
| Revenue (Rs Cr) | 168 | 178 | +6% |
| PAT (Rs Cr) | 52 | 58 | +12% |
| EBITDA Margin | — | 32.6% | Improvement expected |
| Results Date | — | May 2026 | — |
| Dividend History | Rs 8.00 per share | ||
| Dividend Expectation | Rs 10.00 final dividend expected | ||
Estimates based on analyst consensus as of April 2026. Actual results may vary.
Track Nucleus Software Exports live price, FII/DII activity and fundamentals on Univest Screener
5 Reasons Nucleus Software Exports Q4 Results Could Beat Estimates
Deal Win Momentum
Large-deal TCV is building across cloud migration, ERP modernisation, AI-augmented services and managed infrastructure. Multi-year contracts provide strong near-term revenue visibility and reduce quarterly earnings variability significantly.
Generative AI Revenue Contribution
AI-led project wins are now contributing meaningfully to reported revenue. Productivity tools, AI platform services and enterprise automation use cases are gaining rapid corporate adoption across verticals.
Cost Structure Improvement
Fresher hiring, utilisation optimisation and subcontracting rationalisation are supporting EBIT margin recovery even in a slow-revenue environment, with companies guiding for 50 to 100 basis points of improvement.
BFSI and Healthcare Vertical Resilience
Banking, financial services and healthcare tech spending has remained relatively resilient, providing revenue cushion against weakness in discretionary retail and hi-tech verticals.
Currency Tailwind on USD Revenue
A modestly weaker rupee against USD provides a positive tailwind for rupee-denominated revenues and margins on dollarised contracts, offering a natural hedge for the business.
5 Key Risks to Watch in Nucleus Software Exports Q4 Results
Global Macro Uncertainty
US and EU growth concerns, geopolitical conflicts and interest rate volatility may delay enterprise technology spending decisions further, prolonging the slow discretionary recovery.
Discretionary Spend Weakness
Retail, hi-tech and telecom vertical clients remain cautious on new discretionary project investments, limiting new project ramp-ups.
AI Talent Cost Inflation
Rising compensation demands for AI, ML and cloud-specialised talent compresses margins in the fastest-growing service lines.
GCC Competition Risk
Growth of Global Capability Centres in India is shifting some IT services work in-house for large global enterprises, gradually reducing the addressable outsourcing market.
BFSI Client Concentration Risk
Overweight exposure to banking clients creates sensitivity to financial sector regulatory changes and credit cycle disruptions that can cause sudden budget freezes.
Analyst Ratings and Target Price for Nucleus Software Exports
| Brokerage | Rating | Key Thesis |
|---|---|---|
| CLSA | Outperform | AI deal wins to drive revenue re-acceleration |
| JPMorgan | Neutral | Near-term macro headwinds offset by deal strength |
| Kotak Institutional | Buy | Margin improvement and AI revenue upside ahead |
Analyst ratings are for informational purposes only. Not investment advice.
Frequently Asked Questions — Nucleus Software Exports Q4 Results 2026
Q: When will Nucleus Software Exports announce Q4 FY26 results?
Nucleus Software Exports is expected to announce Q4 FY26 results in May 2026. Track the exact date on Univest Screener.
Q: What revenue is expected for Nucleus Software Exports Q4 FY26?
Analyst consensus estimates Nucleus Software Exports Q4 FY26 revenue at approximately Rs 178 Cr, representing approximately 6% year-on-year growth.
Q: What PAT is expected for Nucleus Software Exports in Q4 FY26?
Estimated PAT for Nucleus Software Exports Q4 FY26 is approximately Rs 58 Cr, up approximately 12% year-on-year.
Q: Will Nucleus Software Exports declare a dividend in Q4 FY26?
Historical dividend pattern: Rs 8.00 per share. Q4 FY26 expectation: Rs 10.00 final dividend expected.
Q: What is the current share price of Nucleus Software Exports?
Nucleus Software Exports (NUCLEUS) is currently trading at approximately Rs 568 with a market capitalisation of Rs 1,650 Cr. Track live on Univest Screener.
Q: Is Nucleus Software Exports a buy before Q4 results?
This article does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decision.
Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. SEBI Registration: INH000012449.
Recent Article
VRL Logistics Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Vraj Iron and Steel Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Voltas Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Voltamp Transformers Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Vodafone Idea Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
